| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 476,513 | 397,532 | ||
| Accounts receivable | 30,167 | 20,925 | ||
| Receivables from collaboration arrangement | 63,352 | 67,336 | ||
| Inventory | 38,363 | 48,996 | ||
| Prepaid expenses | 19,415 | 16,610 | ||
| Current portion of isp fund investments | 56,589 | 100,198 | ||
| Other current assets | 171 | 181 | ||
| Total current assets | 684,570 | 651,778 | ||
| Property and equipment, net | 1,529 | 451 | ||
| Equity method investments | 82,577 | 51,826 | ||
| Equity and long-term investments | 343,794 | 297,284 | ||
| Capitalized fees paid, net | 59,593 | 63,049 | ||
| Right-of-use assets | 1,402 | 1,759 | ||
| Goodwill | 17,905 | 17,905 | ||
| Intangible assets | 188,793 | 195,411 | ||
| Deferred tax assets, net | 7,982 | 12,931 | ||
| Other assets | 40,961 | 41,178 | ||
| Total assets | 1,429,106 | 1,333,572 | ||
| Accounts payable | 6,243 | 5,382 | ||
| Accrued personnel-related expenses | 6,819 | 4,750 | ||
| Accrued interest payable | 231 | 3,418 | ||
| Deferred revenue | 13,571 | 3,125 | ||
| Convertible subordinated notes due 2025, net of issuance costs | 0 | 191,903 | ||
| Other accrued liabilities | 21,607 | 37,985 | ||
| Total current liabilities | 48,471 | 246,563 | ||
| Long-term debt, net of discount and issuance costs | 257,377 | 257,019 | ||
| Other long-term liabilities | 57,431 | 60,021 | ||
| Income tax payable, long-term | 55,876 | 55,148 | ||
| Common stock 0.01 par value, 200,000 shares authorized, 74,769 and 62,665 issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 748 | 630 | ||
| Additional paid-in capital | 903,988 | 698,884 | ||
| Retained earnings (accumulated deficit) | 105,215 | 15,307 | ||
| Total stockholders' equity | 1,009,951 | 714,821 | ||
| Total liabilities and stockholders' equity | 1,429,106 | 1,333,572 | ||
Innoviva, Inc. (INVA)
Innoviva, Inc. (INVA)